Related references
Note: Only part of the references are listed.Veno-Occlusive Disease as a Complication of Preoperative Chemotherapy for Wilms Tumor: A Clinico-Pathological Analysis
Charissa T. Jagt et al.
PEDIATRIC BLOOD & CANCER (2009)
Vincristine: Can Its Therapeutic Index Be Enhanced?
Andrew Moore et al.
PEDIATRIC BLOOD & CANCER (2009)
Population pharmacokinetic investigation of actinomycin-D in children and young adults
John T. Mondick et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients
Jamie L. Renbarger et al.
PEDIATRIC BLOOD & CANCER (2008)
Selective metabolism of vincristine in vitro by CYP3A5
Jennifer B. Dennison et al.
DRUG METABOLISM AND DISPOSITION (2006)
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group study
GJ Veal et al.
CLINICAL CANCER RESEARCH (2005)
Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide
C Arndt et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
